This review examines how multi-omics, single-cell and spatial methods, liquid biopsy, and artificial intelligence are enabling more informative disease models, and how these advances can improve screening, diagnosis, primary treatment selection, residual disease detection, and monitoring of ongoing outcomes.
I. Daniels, A. Page, D. Wise· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.